KEGG   DRUG: Labetuzumab
Entry
D08936                      Drug                                   
Name
Labetuzumab (INN/USAN)
Efficacy
Antineoplastic, Anti-CEA antibody
  Type
Monoclonal antibody
Comment
Treatment of colorectal cancer
Target
CEACAM [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: Ig superfamiy
   CAMs
    CEACAM
     D08936  Labetuzumab (INN/USAN)
Other DBs
CAS: 219649-07-7
PubChem: 96025619

» Japanese version   » Back

DBGET integrated database retrieval system